|
Navigation
Search
|
Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial
Saturday November 11, 2023. 02:30 PM , from Wired: Cult of Mac
The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths.
https://www.wired.com/story/wegovy-slashes-the-risk-of-heart-attack-and-stroke-in-a-landmark-trial/
|
46 sources
Current Date
May, Thu 9 - 16:38 CEST
|
Read more at Wired: Cult of Mac